IP Library Assignment 030133/0200
Patent Assignment
Reel/Frame 030133/0200

Merger

Recorded: 2013-04-02 Pages: 5
Assignor
MERCK SHARP & DOHME CORP.
Executed: 2012-04-26
Assignee
SCHERING CORPORATION
2000 GALLOPING HILL ROAD, KENILWORTH, NEW JERSEY, 07033-0530
Covered Properties (23)
Methods of using saha and bortezomib for treating cancer
Application: 12/154,087 →
Publication: US US20090247549A1
Processes and Apparatuses for the Production of Crystalline Pharmaceutical Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use
Application: 12/282,043 →
Publication: US US20090087492A1
Piperidines and Related Compounds for the Treatment of Alzheimer's Disease
Patent: 8,389,547 →
Application: 12/298,394 →
Publication: US US20100048623A1
Vaccine for the Treatment of Alzheimer's Disease
Application: 12/496,823 →
Publication: US US20110002949A1
Cetp Inhibitors
Patent: 8,735,435 →
Application: 12/625,783 →
Publication: US US20100099716A1
Triazole Derivatives for Treating Alzheimer's Disease and Related Conditions
Patent: 8,242,150 →
Application: 12/663,432 →
Publication: US US20100222320A1
Lyophilized Anti-Fungal Composition
Application: 12/666,426 →
Publication: US US20100137197A1
Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
Patent: 8,304,434 →
Application: 12/678,454 →
Publication: US US20100210620A1
Formulations of Suberoylanilide Hydroxamic Acid and Methods for Producing Same
Patent: 8,288,440 →
Application: 12/686,812 →
Publication: US US20100119596A1
Substituted Diazepan Orexin Receptor Antagonists
Patent: 8,362,009 →
Application: 12/739,304 →
Publication: US US20100256121A1
3,4-Substituted Pyrrolidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Patent: 8,354,545 →
Application: 12/747,605 →
Publication: US US20100280009A1
Isoquinolinone Potassium Channel Inhibitors
Patent: 8,338,449 →
Application: 12/753,572 →
Publication: US US20100256698A1
Spirocyclic Compounds
Patent: 8,349,825 →
Application: 12/912,094 →
Publication: US US20110098268A1
Substituted Naphthyridine Compounds as Inhibitors of Akt Activity
Patent: 8,288,407 →
Application: 13/046,322 →
Publication: US US20110160183A1
Hiv Integrase Inhibitors
Patent: 8,293,731 →
Application: 13/107,512 →
Publication: US US20110275621A1
Substituted Imidazoles as Bombesin Receptor Subtype-3 Modulators
Patent: 8,318,767 →
Application: 13/327,093 →
Publication: US US20120088788A1
Novel TRPA1 Antagonists
Patent: 8,829,196 →
Application: 13/499,844 →
Publication: US US20120196894A1
Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors with Pioglitazone
Application: 13/501,252 →
Publication: US US20120201885A1
Quinolizidinone Carboxamide M1 Receptor Positive Allosteric Modulators
Patent: 8,754,220 →
Application: 13/510,089 →
Publication: US US20120232076A1
Methods and Compositions for Preventing and Treating Heartburn
Patent: 5,989,588 →
Application: 08/940,643 →
Topical Invermectin Composition
Patent: 7,064,108 →
Application: 10/504,262 →
Publication: US US20050143325A1
Alpha V Integrin Receptor Antagonists
Patent: 7,288,655 →
Application: 10/547,407 →
Publication: US US20060149069A1
Crystalline Forms of Carbapenem Antibiotics and Methods of Preparation
Patent: 40,794 →
Application: 11/999,720 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 17, 2012
From: KUDUK, SCOTT D.; GRESHOCK, THOMAS; CHANG, RONALD K.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028226/0651 →
Change of Name Apr 2, 2013
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 030137/0837 →
Nunc Pro Tunc Assignment Aug 5, 2021
From: MERCK SHARP & DOHME LIMITED
To: MERCK SHARP & DOHME (UK) LIMITED
Reel/Frame 057089/0547 →
Change of Address May 10, 2022
From: MERCK SHARP & DOHME (UK) LIMITED
To: MERCK SHARP & DOHME (UK) LIMITED
Reel/Frame 060110/0121 →
Merger Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →